188
Participants
Start Date
April 30, 2015
Primary Completion Date
May 31, 2016
Study Completion Date
June 30, 2016
etanercept
50mg subcutaneous, once weekly, 24 weeks
Qualiclinic Kft., Budapest
"DCC Aleksandrovska EOOD", Sofia
"UMHAT Sv. Ivan Rilski EAD, Sofia", Sofia
Pest Megyei Flor Ferenc Korhaz, Kistarcsa
Wits Clinical Research CMJAH Clinical Trial Site, Parktown
MHAT Plovdiv, Plovdiv
St. Augustines Hospital, Durban/Berea
Szabolcs-Szatmar-Bereg megyei, Nyíregyháza
"Medical Center - New rehabilitation center EOOD", Stara Zagora
Panorama Medical Centre, Panorama
Medicinski Centar Kuna Peric, Zagreb
Institute of Rheumatology, Belgrade
Schlosspark-Klinik, Innere Medizin II, Rheumatologie, Berlin
Rheumatology Department, Rion Patras
Medizinische Hochschule Hannover, Hanover
Immunologisches Zentrum Vogelsang-Gommern GmbH, Vogelsang-Gommern
Rheumaforschung - Studienambulanz Dr. Wassenberg, Ratingen
Chc Rijeka, Rijeka
Rheumatology Unit, Thessaloniki
Centrum für innovative Diagnostik und Therapie, Frankfurt am Main
University Hospital of Heraklion, Heraklion
Krakowskie Centrum Medyczne sp. Z.O.O, Krakow
NZOZ Lecznica MAK-MED s.c., Nadarzyn
Prywatna Praktyka Lekarska Prof. UM dr hab.med. Pawel Hrycaj, Poznan
Reumatika-Centrum Reumatologii, Warsaw
Reumatologicka ambulancia, Bratislava
AAGS, s.r.o., Dunajská Streda
Reumatologicka ambulancia, MUDr. Zuzana Cizmarikova, s.r.o., Poprad
REUMEX s.r.o., Rimavská Sobota
REUMA-GLOBAL s.r.o., Trnava
Reumatologicka ambulancia, Žilina
Lead Sponsor
Pfizer
INDUSTRY